131 related articles for article (PubMed ID: 35342300)
1. LAMC1 is a Novel Prognostic Factor and a Potential Therapeutic Target in Gastric Cancer.
Xi D; Jia Q; Liu X; Zhang L; Xu B; Ma Z; Ma Y; Yu Y; Zhang F; Chen H
Int J Gen Med; 2022; 15():3183-3198. PubMed ID: 35342300
[TBL] [Abstract][Full Text] [Related]
2. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
3. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
4. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
5. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
[TBL] [Abstract][Full Text] [Related]
6. FKBP10 Acts as a New Biomarker for Prognosis and Lymph Node Metastasis of Gastric Cancer by Bioinformatics Analysis and in Vitro Experiments.
Gong LB; Zhang C; Yu RX; Li C; Fan YB; Liu YP; Qu XJ
Onco Targets Ther; 2020; 13():7399-7409. PubMed ID: 32801763
[TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
8. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
9. EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer.
Zheng P; Liu X; Li H; Gao L; Yu Y; Wang N; Chen H
Front Genet; 2021; 12():796592. PubMed ID: 35126464
[No Abstract] [Full Text] [Related]
10. ICAM1 Regulates the Development of Gastric Cancer and May Be a Potential Biomarker for the Early Diagnosis and Prognosis of Gastric Cancer.
Chen S; Pan S; Wu H; Zhou J; Huang Y; Wang S; Liu A
Cancer Manag Res; 2020; 12():1523-1534. PubMed ID: 32184657
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Cyclin-Dependent Kinase 1 as an Independent Prognostic Factor for Gastric Cancer Based on Statistical Methods.
Zhang X; Ma H; Zou Q; Wu J
Front Cell Dev Biol; 2020; 8():620164. PubMed ID: 33365314
[TBL] [Abstract][Full Text] [Related]
12. Identification of key genes with prognostic value in gastric cancer by bioinformatics analysis.
Wang R; Chen X; Huang C; Yang X; He H; OuYang C; Li H; Guo J; Yang C; Lin Z
Front Genet; 2022; 13():958213. PubMed ID: 36110205
[No Abstract] [Full Text] [Related]
13. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
Li D; Yin Y; He M; Wang J
Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
[TBL] [Abstract][Full Text] [Related]
14. BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer.
Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
Front Genet; 2022; 13():765569. PubMed ID: 35154268
[No Abstract] [Full Text] [Related]
15. A nine-gene signature as prognostic biomarker in gastric cancer by bioinformatics analysis.
Wang G; Ren Z; Zhao Y; Li Y
Clin Transl Oncol; 2023 Nov; 25(11):3296-3306. PubMed ID: 37041435
[TBL] [Abstract][Full Text] [Related]
16. Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer.
Chen PF; Wang F; Nie JY; Feng JR; Liu J; Zhou R; Wang HL; Zhao Q
Onco Targets Ther; 2018; 11():6425-6436. PubMed ID: 30323620
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
18. [Expression of PTTG1 in gastric adenocarcinoma tissues and its relationship with prognosis].
Yao NH; Chen ZM; Shi Y; Yan XD; Lyu LT; Liu J; Xuan TT; Qian J; Zhao HY
Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):306-311. PubMed ID: 33752310
[No Abstract] [Full Text] [Related]
19. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
[No Abstract] [Full Text] [Related]
20. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
Hu C; Zhou Y; Liu C; Kang Y
Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
